Fresenius Medical Care AG

Informe acción XTRA:FME

Capitalización de mercado: €11.5b

Fresenius Medical Care Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Fresenius Medical Care de 21.9% y 3.6% por año respectivamente. Se prevé que el BPA crezca en un 21.3% al año. Se espera que la rentabilidad financiera sea de 7.5% en 3 años.

Información clave

20.9%

Tasa de crecimiento de los beneficios

20.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare23.2%
Tasa de crecimiento de los ingresos3.6%
Rentabilidad financiera futura7.4%
Cobertura de analistas

Good

Última actualización03 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Apr 26
Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 29
Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Mar 14
Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

Feb 23
Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Feb 22
When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Feb 03
Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Jan 16
Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Dec 29
Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Nov 21
Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Oct 16
Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Sep 28
Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Aug 21
Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Jul 23
An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

Jul 09
Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

Jun 25
These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

May 07
What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

Apr 23
Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Mar 24
We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Feb 03
Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Jan 19
Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Jan 04
Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Dec 17
Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think

Nov 08
Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think

Is It Too Late To Consider Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Oct 25
Is It Too Late To Consider Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Sep 15
Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Aug 10
Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Previsiones de crecimiento de beneficios e ingresos

XTRA:FME - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/202621,2781,1771,6292,69013
12/31/202520,3479691,9252,62619
12/31/202419,6216941,8692,40518
12/31/202319,4544991,9182,629N/A
9/30/202319,4634501,7992,509N/A
6/30/202319,6225961,6742,407N/A
3/31/202319,5546021,4012,152N/A
12/31/202219,3986731,3972,167N/A
9/30/202219,0487631,4442,237N/A
6/30/202218,3938061,4442,271N/A
3/31/202217,9578781,5762,441N/A
12/31/202117,6199691,6032,489N/A
9/30/202117,3729181,4772,405N/A
6/30/202117,3449981,4802,459N/A
3/31/202117,5811,1312,8693,857N/A
12/31/202017,8591,1643,1484,233N/A
9/30/202018,0391,3303,2994,420N/A
6/30/202018,0441,3093,3774,542N/A
3/31/202017,8321,2121,8323,075N/A
12/31/201917,4771,2001,4042,567N/A
9/30/201917,1961,2821,3672,494N/A
6/30/201916,8351,2341,2462,379N/A
3/31/201916,7041,9741,0652,182N/A
12/31/201816,5471,9829202,062N/A
9/30/201816,6761,9517661,892N/A
6/30/201816,9541,9756841,750N/A
3/31/201817,2111,2509821,977N/A
12/31/201717,7841,2801,2212,192N/A
9/30/201717,7711,249N/A2,436N/A
6/30/201717,6471,244N/A2,217N/A
3/31/201717,2011,239N/A1,938N/A
12/31/201616,5701,144N/A1,932N/A
9/30/201616,1011,063N/A1,648N/A
6/30/201615,841998N/A1,782N/A
3/31/201615,402933N/A1,491N/A
12/31/201515,455955N/A1,767N/A
9/30/201515,345939N/A1,791N/A
6/30/201515,246948N/A1,914N/A
3/31/201515,428977N/A2,044N/A
12/31/201413,329864N/A1,538N/A
9/30/201412,413839N/A1,476N/A
6/30/201411,112775N/A1,283N/A
3/31/201410,882791N/A1,329N/A
12/31/201310,816806N/A1,478N/A
9/30/201310,881752N/A1,491N/A
6/30/201311,135781N/A1,498N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (21.9% al año) de FME es superior a la tasa de ahorro (0.6%).

Beneficios vs. Mercado: Se prevé que los beneficios (21.9% al año) de FME crezcan más rápidamente que el mercado German (14% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de FME crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.6% al año) de FME crezcan más despacio que el mercado de German (5.2% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.6% al año) de FME crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de FME sea baja dentro de 3 años (7.5%).


Descubre empresas en crecimiento